Plus Therapeutics Secures Up to $18 Million Through Strategic Private Financing. To bolster its financial position and further its research in targeted radiotherapeutics, Plus Therapeutics, Inc. (Nasdaq: PSTV), based out of Austin, Texas, has announced a substantial private placement financing agreement. The deal, set to raise up to approximately $18 million in gross proceeds, has been orchestrated with the support of ne...
Breakthrough in Pediatric Brain Cancer Research: Plus Therapeutics Secures $3 Million DoD Award. In an unprecedented move that signals a new era for cancer treatment, Plus Therapeutics, Inc., a trailblazer in the development of targeted radiotherapeutics, has been awarded a $3 million grant by the Department of Defense (DoD) through its Congressionally Directed Medical Research Programs (CDMRP). This s...
$プラス セラピューティクス(PSTV.US)$Plus Therapeutics Announces Validation & Clinical Implementation Of CSF-01 Leptomeningeal Cancer Cell Diagnostic Benzinga· 3 mins ago
プラス セラピューティクスに関するコメント
To bolster its financial position and further its research in targeted radiotherapeutics, Plus Therapeutics, Inc. (Nasdaq: PSTV), based out of Austin, Texas, has announced a substantial private placement financing agreement. The deal, set to raise up to approximately $18 million in gross proceeds, has been orchestrated with the support of ne...
NEWS
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
In an unprecedented move that signals a new era for cancer treatment, Plus Therapeutics, Inc., a trailblazer in the development of targeted radiotherapeutics, has been awarded a $3 million grant by the Department of Defense (DoD) through its Congressionally Directed Medical Research Programs (CDMRP). This s...
Benzinga· 3 mins ago
Salvation is coming, perhaps !
nice dips
まだコメントはありません